Hornhaut Entferner Zur Äußerlichen Anwendung Bei Erwachsenen Und Kindern Ab 6 Jahren (Salicylic Acid)

Hornhaut Entferner is indicated for the topical management of hyperkeratotic skin conditions on the feet and hands.

• Removal of plantar calluses that cause discomfort or pressure pain.
• Softening and elimination of corns (heloma) on toes or fingers.
• Treatment of localized hyperkeratosis due to friction or pressure.
• Preparation of thick skin before podiatric procedures or orthotic fitting.
• Adjunctive care for mild keratoderma when mechanical debridement is not feasible.

• Salicylic acid works as a keratinolytic agent by breaking the bonds that hold keratin proteins together in the stratum corneum. The acid lowers the local pH, enhancing the activity of skin proteases that dissolve corneocyte connections. This controlled desquamation thins hyperkeratotic plaques and allows the softened callus to be removed with minimal irritation to deeper skin layers. The effect is localized to the applied area and does not involve systemic absorption in therapeutic amounts.

Topical application of salicylic‑acid callus remover may cause local skin reactions; most are mild and reversible.

Common

• Mild erythema or redness at the application site.
• Transient burning or stinging sensation during or shortly after use.
• Dryness or flaking of the treated skin.
• Itching or mild pruritus.
• Slight peeling as the keratin layer loosens.
• Temporary discoloration or whitening of the skin.

Serious

• Allergic contact dermatitis presenting with intense redness, swelling, and vesicles.
• Severe burning or ulceration of the skin.
• Persistent swelling or edema beyond the treated area.
• Hyperpigmentation or hypopigmentation after prolonged use.
• Development of secondary infection if the skin barrier is compromised.
• Excessive tissue necrosis requiring medical attention.

When using this salicylic‑acid callus remover, certain precautions help minimize adverse reactions and ensure safe application.

• Do not apply to healthy, intact skin; limit use to thickened hyperkeratotic areas.
• Avoid contact with eyes, mucous membranes, or broken skin.
• Test on a small skin area first to assess tolerance.
• Keep the product away from children; store out of reach.
• Do not use under occlusive dressings unless directed by a healthcare professional.
• Discontinue use if severe irritation or allergic reaction occurs.
• Consult a physician before use on diabetic foot lesions or other compromised skin.

Salicylic‑acid topical agents can interact with other skin products or systemic medications; awareness of these interactions helps avoid reduced efficacy or increased irritation.

Avoid

• Concurrent use with other keratolytic or exfoliating agents (e.g., glycolic acid, urea) on the same area.
• Application together with topical retinoids or corticosteroids without a washout period.
• Use on skin pre‑treated with chemical peels or laser therapy.

Use with caution

• Combining with systemic salicylate‑containing drugs (e.g., aspirin) may increase overall salicylate exposure, especially in children.
• Use with occlusive dressings may enhance absorption; limit duration.
• Applying near large surface areas may increase systemic absorption; monitor for signs of toxicity.